Skip to main content

and
  1. Article

    Open Access

    Comparison of the cost-effectiveness of sequential treatment with abaloparatide in US men and women at very high risk of fractures

    Osteoporotic-related fractures represent an increasing burden to patients, health care systems and society.

    Mickael Hiligsmann, Stuart L. Silverman in Aging Clinical and Experimental Research (2024)

  2. Article

    Open Access

    Cost-Effectiveness of Sequential Abaloparatide/Alendronate in Men at High Risk of Fractures in the United States

    Abaloparatide (ABL) significantly increases bone mineral density in men with osteoporosis similar to what was reported in postmenopausal women with osteoporosis. The cost effectiveness of sequential treatment ...

    Mickaël Hiligsmann, Stuart S. Silverman, Andrea J. Singer in PharmacoEconomics (2023)

  3. Article

    Open Access

    Correction to: Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review

    Nannan Li, Charlotte Beaudart, Jane A. Cauley, Steven W. Ing in PharmacoEconomics (2023)

  4. Article

    Open Access

    Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review

    Osteoporosis is often considered to be a disease of women. Over the last few years, owing to the increasing clinical and economic burden, the awareness and imperative for identifying and managing osteoporosis ...

    Nannan Li, Charlotte Beaudart, Jane A. Cauley, Steven W. Ing in PharmacoEconomics (2023)

  5. No Access

    Article

    The National Osteoporosis Foundation’s methods and processes for develo** position statements

    The methods and processes described in this manuscript have been approved and adopted by the NOF Board of Trustees on November 11, 2015. This manuscript has been peer-reviewed by the NOF Research Committee and Os...

    Taylor C. Wallace, Douglas C. Bauer, Robert F. Gagel in Archives of Osteoporosis (2016)